325
Views
20
CrossRef citations to date
0
Altmetric
UrologyOriginal Articles

Managing localized prostate cancer by radical prostatectomy or watchful waiting: Cost analysis of a randomized trial (SPCG-4)

, , , , , , & show all
Pages 177-183 | Received 18 Aug 2010, Accepted 16 Nov 2010, Published online: 25 Jan 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Deepika Reddy, Marieke van Son, Max Peters, Mariana Bertoncelli Tanaka, Tim Dudderidge, Emma Cullen, Carmen Lok Tung Ho, Richard G. Hindley, Amr Emara, Stuart McCracken, Clement Orczyk, Iqbal Shergill, Stephen Mangar, Raj Nigam, Jaspal Virdi, Caroline M. Moore, Manit Arya, Taimur T. Shah, Mathias Winkler, Mark Emberton, Alison Falconer, Jonathan Belsey & Hashim U. Ahmed. (2023) Focal therapy versus radical prostatectomy and external beam radiotherapy as primary treatment options for non-metastatic prostate cancer: results of a cost-effectiveness analysis. Journal of Medical Economics 26:1, pages 1099-1107.
Read now
Johan Lyth, Swen-Olof Andersson, Ove Andrén, Jan-Erik Johansson, Per Carlsson & Nosrat Shahsavar. (2012) A decision support model for cost-effectiveness of radical prostatectomy in localized prostate cancer. Scandinavian Journal of Urology and Nephrology 46:1, pages 19-25.
Read now

Articles from other publishers (18)

Sian M. Noble, Kirsty Garfield, J. Athene Lane, Chris Metcalfe, Michael Davis, Eleanor I. Walsh, Richard M. Martin, Emma L. Turner, Tim J. Peters, Joanna C. Thorn, Malcolm Mason, Prasad Bollina, James W. F. Catto, Alan Doherty, Vincent Gnanapragasam, Owen Hughes, Roger Kockelbergh, Howard Kynaston, Alan Paul, Edgar Paez, Derek J. Rosario, Edward Rowe, Jon Oxley, John Staffurth, David E. Neal, Freddie C. Hamdy & Jenny L. Donovan. (2020) The ProtecT randomised trial cost-effectiveness analysis comparing active monitoring, surgery, or radiotherapy for prostate cancer. British Journal of Cancer 123:7, pages 1063-1070.
Crossref
Robin WM Vernooij, Michelle Lancee, Anne Cleves, Philipp Dahm, Chris H Bangma & Katja KH Aben. (2020) Radical prostatectomy versus deferred treatment for localised prostate cancer. Cochrane Database of Systematic Reviews 2020:6.
Crossref
Marc Zanaty, Khaled Ajib, Kevin Zorn & Assaad El-Hakim. (2018) Functional outcomes of robot-assisted radical prostatectomy in patients eligible for active surveillance. World Journal of Urology 36:9, pages 1391-1397.
Crossref
Merehau C Mervin, Anthony Lowe, Robert A Gardiner, David P Smith, Joanne Aitken, Suzanne K Chambers & Louisa G Gordon. (2017) What does it cost Medicare to diagnose and treat men with localized prostate cancer in the first year?. Asia-Pacific Journal of Clinical Oncology 13:3, pages 152-159.
Crossref
L.G. Gordon, S.M. Walker, M.C. Mervin, A. Lowe, D.P. Smith, R.A. Gardiner & S.K. Chambers. (2017) Financial toxicity: a potential side effect of prostate cancer treatment among Australian men. European Journal of Cancer Care 26:1, pages e12392.
Crossref
Alina Brandes, Florian Koerber, Larissa Schwarzkopf, Matthias Hunger, Wolf H. Rogowski & Raphaela Waidelich. (2016) Costs of conservative management of early-stage prostate cancer compared to radical prostatectomy–a claims data analysis. BMC Health Services Research 16:1.
Crossref
Virginia Becerra, Mónica Ávila, Jorge Jimenez, Laura Cortes-Sanabria, Yolanda Pardo, Olatz Garin, Angels Pont, Jordi Alonso, Francesc Cots & Montse Ferrer. (2016) Economic evaluation of treatments for patients with localized prostate cancer in Europe: a systematic review. BMC Health Services Research 16:1.
Crossref
J. Perlbarg, H. Rabetrano, M. Soulié, L. Salomon & I. Durand-Zaleski. (2015) Évaluation médico-économique de la chirurgie et des autres primo-traitements du cancer de la prostate non métastatique. Progrès en Urologie 25:15, pages 1108-1115.
Crossref
Timothy J. WiltRussell P. HarrisAmir Qaseem. (2015) Screening for Cancer: Advice for High-Value Care From the American College of Physicians. Annals of Internal Medicine 162:10, pages 718-725.
Crossref
Mark A. Preston, Anders H. Riis, Vera Ehrenstein, Rodney H. Breau, Julie L. Batista, Aria F. Olumi, Lorelei A. Mucci, Hans-Olov Adami & Henrik T. Sørensen. (2014) Metformin Use and Prostate Cancer Risk. European Urology 66:6, pages 1012-1020.
Crossref
Tengbin Xiong, Rebecca M Turner, Yinghui Wei, David E Neal, Georgios Lyratzopoulos & Julian P T Higgins. (2014) Comparative efficacy and safety of treatments for localised prostate cancer: an application of network meta-analysis. BMJ Open 4:5, pages e004285.
Crossref
A. Dragomir, F. L. Cury & A. G. Aprikian. (2014) Active surveillance for low-risk prostate cancer compared with immediate treatment: a Canadian cost comparison. CMAJ Open 2:2, pages E60-E68.
Crossref
Christian Bolenz, Stephen J. Freedland, Brent K. Hollenbeck, Yair Lotan, William T. Lowrance, Joel B. Nelson & Jim C. Hu. (2014) Costs of Radical Prostatectomy for Prostate Cancer: A Systematic Review. European Urology 65:2, pages 316-324.
Crossref
Hendrik Van Poppel & Steven Joniau. 2013. Imaging and Focal Therapy of Early Prostate Cancer. Imaging and Focal Therapy of Early Prostate Cancer 37 52 .
Ruth Etzioni, Lorelei Mucci, Shu Chen, Jan-Erik Johansson, Katja Fall & Hans-Olov Adami. (2012) Increasing Use of Radical Prostatectomy for Nonlethal Prostate Cancer in Sweden. Clinical Cancer Research 18:24, pages 6742-6747.
Crossref
L. Holmberg, A. Bill-Axelson, G. Steineck, H. Garmo, J. Palmgren, E. Johansson, H.-O. Adami & J.-E. Johansson. (2012) Results From the Scandinavian Prostate Cancer Group Trial Number 4: A Randomized Controlled Trial of Radical Prostatectomy Versus Watchful Waiting. JNCI Monographs 2012:45, pages 230-233.
Crossref
E. Bismarck, B.J. Schmitz-Dräger & O. Schöffski. (2012) Was erwartet die Medizin von der Gesundheitsökonomie?What can medicine expect from health economics?. Der Urologe 51:4, pages 533-538.
Crossref
Luigi Mearini & Massimo Porena. (2011) Pros and Cons of Focal Therapy for Localised Prostate Cancer. Prostate Cancer 2011, pages 1-8.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.